The Mechanosensitive Ion Channel Piezo1 in Fibrotic Diseases
Author:
Affiliation:

1)School of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing 400056, China;2)Chongqing Key Laboratory of Medicinal Chemistry & Molecular Pharmacology, Chongqing 400056, China

Clc Number:

Fund Project:

This work was supported by grants from The National Natural Science Foundation of China (11702044, 11902061) and Natural Science Foundation of Chongqing (cstc2020jcyj-msxmX0350).

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Piezo1 is a newly discovered mechanosensitive ion channel in mammals, which plays important functions in different tissues and organs, including bone, urinary tract, eyeball, and artery. However, abnormal Piezo1 mechanical transmission can cause a variety of diseases and promote the course of disease. Fibrotic disease can occur in almost any tissue and organ, and its main feature is excessive cross-linking and accumulation of collagen and other extracellular matrix components, which eventually leads to increased stiffness of tissues and organs and affected physiological functions. At present, more and more studies have shown that Piezo1 plays an important regulatory role in the occurrence and development of fibrotic diseases, which is closely related to the change of matrix mechanical state. This paper describes the structure and activation mechanism of Piezo1, and systematically summarizes the research progress of Piezo1 in fibrotic diseases of the heart, kidney, pancreas, liver and other organs, in order to provide a new perspective and strategy for the treatment of fibrotic diseases.

    Reference
    Related
    Cited by
Get Citation

YIN Shi-Yun, CHEN Guo-Bao. The Mechanosensitive Ion Channel Piezo1 in Fibrotic Diseases[J]. Progress in Biochemistry and Biophysics,2023,50(11):2580-2590

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:September 10,2022
  • Revised:October 11,2023
  • Accepted:November 29,2022
  • Online: November 22,2023
  • Published: November 20,2023